Maiva Pharma, a Bengaluru CDMO, raised $130m from Morgan Stanley and India Life Sciences for a new manufacturing facility in Hosur, India to produce sterile dosage forms.

Maiva Pharma, a Bengaluru-based CDMO, raised Rs 1,000 crore ($130 million) from Morgan Stanley Private Equity Asia and India Life Sciences Fund. The funds will be used to establish a new manufacturing facility near Hosur, India, with capabilities in various sterile dosage forms, including pre-filled syringes, bags, oncology, and hormonal injectables. This investment marks Maiva's first private equity fundraise and will help the company expand in the rapidly growing Indian healthcare sector.